ARCHIVES

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

This article is from The Cancer Letter archive.

Vol. 39 No. 09 | March 1, 2013

Download PDF Visit The Full Archive

Related Articles

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

Breast Implants Lessen Ability Of Mammograms To Find Cancer

February 27, 2004

Obama Administration, WellPoint, Face Off Over Allegation Of Coverage Recissions

April 30, 2010

House Figures for NCI, NIH Will Be Known This Week; Senate Probably Will Wait Until After Recess

July 31, 1987

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

April 29, 2005

FDA Issues Final Regs for Mammography Facilities, Personnel

November 7, 1997